Your browser doesn't support javascript.
loading
Vaccinomics: A scoping review.
Dudley, Matthew Z; Gerber, Jennifer E; Budigan Ni, Haley; Blunt, Madeleine; Holroyd, Taylor A; Carleton, Bruce C; Poland, Gregory A; Salmon, Daniel A.
Afiliação
  • Dudley MZ; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: mattdudley@jhu.edu.
  • Gerber JE; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Survey Research Division, RTI International, Washington, DC, USA.
  • Budigan Ni H; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Office of Health Equity, California Department of Public Health, Richmond, CA, USA.
  • Blunt M; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Holroyd TA; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Carleton BC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, BC, Canada; BC Children's Hospital Research Institute, Vancouver, BC, Canada.
  • Poland GA; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA; Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Salmon DA; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Department of Health, Behavior & Society, Johns Hopkins University Blo
Vaccine ; 41(14): 2357-2367, 2023 03 31.
Article em En | MEDLINE | ID: mdl-36803903
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Rubéola (Sarampo Alemão) / Influenza Humana / Sarampo Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Rubéola (Sarampo Alemão) / Influenza Humana / Sarampo Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article